| Primary |
| Product Used For Unknown Indication |
57.1% |
| Anaemia |
14.3% |
| Blood Disorder |
14.3% |
| Suicide Attempt |
14.3% |
|
| Completed Suicide |
16.7% |
| Death |
16.7% |
| Medication Error |
16.7% |
| Pain In Extremity |
16.7% |
| Product Odour Abnormal |
16.7% |
| Suicide Attempt |
16.7% |
|
| Secondary |
| Product Used For Unknown Indication |
46.4% |
| Drug Use For Unknown Indication |
21.7% |
| Crohn's Disease |
4.9% |
| Drug Dependence |
3.0% |
| Anaemia |
2.9% |
| Colorectal Cancer Metastatic |
2.3% |
| Hypertension |
1.7% |
| Drug Exposure During Pregnancy |
1.6% |
| Anxiety |
1.5% |
| Colitis Ulcerative |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
| Suicide Attempt |
1.5% |
| Mineral Supplementation |
1.4% |
| Back Pain |
1.3% |
| Nausea |
1.3% |
| Pregnancy |
1.3% |
| Rheumatoid Arthritis |
1.2% |
| Completed Suicide |
1.1% |
| Dementia Alzheimer's Type |
1.1% |
| Bipolar Disorder |
1.0% |
|
| Completed Suicide |
12.1% |
| Toxicity To Various Agents |
11.2% |
| Poisoning |
6.9% |
| Pulmonary Embolism |
6.0% |
| Urticaria |
6.0% |
| Weight Decreased |
6.0% |
| Drug Hypersensitivity |
5.2% |
| Swelling Face |
5.2% |
| Death |
4.3% |
| Drug Toxicity |
4.3% |
| Weight Increased |
4.3% |
| Drug Exposure During Pregnancy |
3.4% |
| Hypotension |
3.4% |
| Intentional Overdose |
3.4% |
| Patent Ductus Arteriosus |
3.4% |
| Persistent Foetal Circulation |
3.4% |
| Thrombosis |
3.4% |
| Adverse Drug Reaction |
2.6% |
| Anaemia |
2.6% |
| Nausea |
2.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
37.4% |
| Drug Use For Unknown Indication |
20.2% |
| Crohn's Disease |
7.0% |
| Rheumatoid Arthritis |
4.0% |
| Hypertension |
3.8% |
| Pain |
3.4% |
| Anaemia |
3.2% |
| Depression |
2.5% |
| Vitamin Supplementation |
2.2% |
| Mineral Supplementation |
2.0% |
| Diabetes Mellitus |
1.8% |
| Osteoporosis |
1.7% |
| Supplementation Therapy |
1.7% |
| Gastrooesophageal Reflux Disease |
1.6% |
| Prophylaxis |
1.5% |
| Blood Cholesterol Increased |
1.2% |
| Multiple Myeloma |
1.2% |
| Paroxysmal Nocturnal Haemoglobinuria |
1.2% |
| Asthma |
1.2% |
| Anxiety |
1.1% |
|
| Vomiting |
16.0% |
| Weight Decreased |
10.6% |
| Weight Increased |
6.3% |
| Death |
6.1% |
| Pain |
5.1% |
| Injection Site Pain |
4.9% |
| Pyrexia |
4.9% |
| Drug Ineffective |
4.3% |
| Urinary Tract Infection |
4.2% |
| Nausea |
4.2% |
| Therapeutic Response Decreased |
4.1% |
| Pneumonia |
3.7% |
| Pulmonary Embolism |
3.7% |
| Pruritus |
3.3% |
| Dyspnoea |
3.2% |
| Headache |
3.2% |
| Sepsis |
3.1% |
| Vision Blurred |
3.0% |
| Anaemia |
3.0% |
| Haemoglobin Decreased |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Product Used For Unknown Indication |
11.5% |
| Gastrooesophageal Reflux Disease |
5.8% |
| Blood Cholesterol Increased |
3.8% |
| Depression |
3.8% |
| Hypothyroidism |
3.8% |
| Mineral Supplementation |
3.8% |
| Otitis Media |
3.8% |
| Smoking Cessation Therapy |
3.8% |
| Blood Iron Decreased |
1.9% |
| Gastrointestinal Stromal Tumour |
1.9% |
| Insomnia |
1.9% |
| Panic Attack |
1.9% |
| Vitamin Supplementation |
1.9% |
|
| Faeces Discoloured |
21.1% |
| Mania |
10.5% |
| Mental Status Changes |
10.5% |
| Drug Interaction |
5.3% |
| Haemoglobin Decreased |
5.3% |
| Haemorrhoidal Haemorrhage |
5.3% |
| Insomnia |
5.3% |
| Liver Injury |
5.3% |
| Loss Of Consciousness |
5.3% |
| Nausea |
5.3% |
| Paranoia |
5.3% |
| Sluggishness |
5.3% |
| Speech Disorder |
5.3% |
| Treatment Failure |
5.3% |
|
